Because SDC2 methylation was not detectable in most subjects with NED, combination of SDC2 gene with BMP3, NDRG4, or other genetic and epigenetic biomarkers may improve its sensitivity for detecting CRC without losing specificity. This evidence concerns the gene SDC2 and colorectal carcinoma.